Staar Surgical(STAA)
$26.69+2.82 (+11.81%)
STAA
Staar Surgical financials statements
$26.69
At close:+2.82 (+11.81%)
Want to see STAA full AI Analyst Report?
Staar Surgical (STAA) Ratios
573 Followers
Staar Surgical Ratios
STAA's free cash flow for Q3 2026 was $26.38M. For the 2026 fiscal year, STAA's free cash flow was decreased by $-935.00K and operating cash flow was $27.32M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.55 | 5.23 | 5.62 | 6.03 | 5.56 |
| Quick Ratio | 3.74 | 4.62 | 5.08 | 5.56 | 5.21 |
| Cash Ratio | 2.24 | 2.05 | 2.81 | 1.67 | 4.09 |
| Solvency Ratio | -0.67 | -0.12 | 0.26 | 0.53 | 0.36 |
| Operating Cash Flow Ratio | -0.50 | 0.22 | 0.22 | 0.69 | 0.90 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 204.05M | $ 255.75M | $ 262.53M | $ 229.02M | $ 184.19M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.08 | 0.08 | 0.07 | 0.07 | 0.09 |
| Debt-to-Equity Ratio | 0.11 | 0.10 | 0.09 | 0.09 | 0.12 |
| Debt-to-Capital Ratio | 0.10 | 0.09 | 0.08 | 0.08 | 0.11 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.31 | 1.28 | 1.27 | 1.25 | 1.34 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 873.37 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 877.34 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.77 | 0.79 | 0.74 | 0.65 | 0.68 |
| Net Debt to EBITDA | 1.55 | 48.78 | -4.43 | -1.15 | -4.53 |
| Profitability Margins | |||||
| Gross Profit Margin | 76.19% | 76.32% | 78.36% | 78.55% | 77.51% |
| EBIT Margin | -34.36% | -2.88% | 8.71% | 15.40% | 14.47% |
| EBITDA Margin | -30.88% | -0.69% | 10.30% | 16.99% | 16.05% |
| Operating Profit Margin | -19.19% | -4.02% | 8.71% | 15.40% | 14.47% |
| Pretax Profit Margin | -34.36% | -2.88% | 10.45% | 16.02% | 13.58% |
| Net Profit Margin | -33.60% | -6.44% | 6.62% | 13.95% | 11.94% |
| Continuous Operations Profit Margin | -33.60% | -6.44% | 6.62% | 13.95% | 11.94% |
| Net Income Per EBT | 97.79% | 223.24% | 63.35% | 87.08% | 87.88% |
| EBT Per EBIT | 179.04% | 71.78% | 119.93% | 104.00% | 93.90% |
| Return on Assets (ROA) | -17.81% | -3.97% | 4.37% | 9.47% | 7.96% |
| Return on Equity (ROE) | -23.37% | -5.09% | 5.53% | 11.80% | 10.64% |
| Return on Capital Employed (ROCE) | -11.99% | -2.87% | 6.63% | 11.93% | 11.23% |
| Return on Invested Capital (ROIC) | -11.55% | -2.85% | 4.16% | 10.29% | 9.75% |
| Return on Tangible Assets | -19.19% | -3.98% | 4.38% | 9.52% | 8.00% |
| Earnings Yield | -6.88% | -1.70% | 1.41% | 1.70% | 0.64% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.41 | 3.96 | 3.29 | 4.31 | 4.95 |
| Payables Turnover | 4.93 | 4.45 | 5.15 | 5.27 | 5.96 |
| Inventory Turnover | 1.03 | 1.72 | 1.99 | 2.53 | 3.00 |
| Fixed Asset Turnover | 2.33 | 2.58 | 3.18 | 3.49 | 3.40 |
| Asset Turnover | 0.53 | 0.62 | 0.66 | 0.68 | 0.67 |
| Working Capital Turnover Ratio | 0.89 | 1.05 | 1.15 | 1.18 | 1.16 |
| Cash Conversion Cycle | 363.93 | 222.81 | 223.79 | 159.97 | 134.12 |
| Days of Sales Outstanding | 82.78 | 92.16 | 110.92 | 84.67 | 73.73 |
| Days of Inventory Outstanding | 355.23 | 212.68 | 183.80 | 144.55 | 121.64 |
| Days of Payables Outstanding | 74.09 | 82.04 | 70.93 | 69.26 | 61.25 |
| Operating Cycle | 438.01 | 304.85 | 294.72 | 229.22 | 195.37 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.69 | 0.32 | 0.30 | 0.74 | 0.93 |
| Free Cash Flow Per Share | -0.81 | -0.16 | -0.07 | 0.37 | 0.64 |
| Dividend Paid and CapEx Coverage Ratio | -5.88 | 0.67 | 0.80 | 1.97 | 3.22 |
| Capital Expenditure Coverage Ratio | -5.88 | 0.67 | 0.80 | 1.97 | 3.22 |
| Operating Cash Flow Coverage Ratio | -0.89 | 0.41 | 0.41 | 1.15 | 1.37 |
| Operating Cash Flow to Sales Ratio | -0.14 | 0.05 | 0.05 | 0.13 | 0.19 |
| Free Cash Flow Yield | -3.42% | -0.64% | -0.24% | 0.76% | 0.70% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -14.57 | -59.05 | 70.94 | 58.72 | 156.67 |
| Price-to-Sales (P/S) Ratio | 4.89 | 3.79 | 4.70 | 8.19 | 18.70 |
| Price-to-Book (P/B) Ratio | 3.40 | 2.99 | 3.92 | 6.93 | 16.67 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -29.21 | -155.08 | -421.37 | 132.29 | 142.17 |
| Price-to-Operating Cash Flow Ratio | -34.17 | 75.63 | 103.77 | 65.22 | 98.05 |
| Price-to-Earnings Growth (PEG) Ratio | -0.05 | 0.31 | -1.51 | 0.99 | 0.52 |
| Enterprise Value Multiple | -14.27 | -501.57 | 41.15 | 47.07 | 112.02 |
| Enterprise Value | 1.06B | 1.08B | 1.37B | 2.27B | 4.14B |
| EV to EBITDA | -14.27 | -501.57 | 41.15 | 47.07 | 112.02 |
| EV to Sales | 4.41 | 3.45 | 4.24 | 8.00 | 17.97 |
| EV to Free Cash Flow | -26.34 | -141.34 | -380.41 | 129.14 | 136.64 |
| EV to Operating Cash Flow | -30.82 | 68.93 | 93.68 | 63.67 | 94.23 |
| Tangible Book Value Per Share | 6.29 | 8.05 | 7.92 | 6.96 | 5.43 |
| Shareholders’ Equity Per Share | 6.94 | 8.09 | 7.95 | 7.00 | 5.48 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.02 | -1.23 | 0.37 | 0.13 | 0.12 |
| Revenue Per Share | 4.83 | 6.39 | 6.64 | 5.93 | 4.88 |
| Net Income Per Share | -1.62 | -0.41 | 0.44 | 0.83 | 0.58 |
| Tax Burden | 0.98 | 2.23 | 0.63 | 0.87 | 0.88 |
| Interest Burden | 1.00 | 1.00 | 1.20 | 1.04 | 0.94 |
| Research & Development to Revenue | 0.17 | 0.17 | 0.14 | 0.13 | 0.15 |
| SG&A to Revenue | 0.79 | 0.63 | 0.22 | 0.19 | 0.19 |
| Stock-Based Compensation to Revenue | 0.13 | 0.09 | 0.07 | 0.07 | 0.06 |
| Income Quality | 0.43 | -0.78 | 0.68 | 0.92 | 1.60 |
Currency in USD
